Management of Advanced HIV: Common Questions Answered

Question 1What does “advanced HIV” mean?

The World Health Organization defines advanced HIV disease in adults and adolescents as a CD4 count below 200 cells/mm³ or a WHO stage 3 or 4 illness. It may occur when HIV is diagnosed late, when treatment has been interrupted, or when ART is not controlling the virus.

A low CD4 count means the immune system is more vulnerable to infections such as tuberculosis, cryptococcosis, Pneumocystis pneumonia and severe bacterial infections. It does not, by itself, determine an individual patient's outcome.

Question 2Is advanced HIV still treatable?

Yes. Antiretroviral therapy can suppress HIV even when the CD4 count is extremely low. Many patients improve substantially when ART is taken consistently and accompanying infections are diagnosed and treated. Recovery depends on factors such as the infections present, organ function, previous ART exposure, drug resistance, nutrition and adherence.

The important message is to seek care promptly and remain engaged in treatment. Advanced HIV is serious, but effective treatment is available.

Question 3Which tests may be required first?

The evaluation is individualized according to symptoms, previous treatment and CD4 count. It may include:

A urine TB-LAM test can help diagnose tuberculosis in selected people with advanced HIV, particularly those who are seriously ill, hospitalized, symptomatic or have very low CD4 counts. It is not a universal screening test for every outpatient.

Question 4When should ART be started?

For most people, ART should begin rapidly after a clinical assessment and discussion of the treatment plan. It should not be postponed simply while waiting for every baseline result. However, the correct timing changes when certain infections involve the brain:

• With cryptococcal meningitis, ART is generally deferred for about four to six weeks after antifungal treatment begins.
• With tuberculous meningitis, ART is usually delayed until the meningitis is clinically controlled and at least two weeks of anti-tuberculosis treatment have been given; the exact timing requires specialist judgment.

For tuberculosis outside the central nervous system, ART is usually started earlier, with timing guided by the CD4 count, clinical status and possible drug interactions.

Question 5Why can symptoms worsen after starting ART?

As the immune system begins to recover, it may produce a strong inflammatory response to an infection already present in the body. This is called immune reconstitution inflammatory syndrome (IRIS). It may cause fever, enlarged lymph nodes or worsening symptoms.

IRIS can often be managed, but similar symptoms may also indicate a new infection, treatment failure or a medicine-related problem. Do not stop ART on your own. Contact the treating doctor promptly for assessment.

Question 6How is recovery monitored?

The viral load should fall after effective ART, and many people achieve viral suppression within several months. This must be confirmed with a viral-load test. CD4 recovery is slower and varies widely; it may continue for one to two years or longer.

Daily treatment without gaps, management of drug interactions, nutrition, vaccinations when appropriate and regular follow-up all support recovery. A documented and maintained viral load below 200 copies/mL prevents sexual transmission of HIV—the evidence-based principle known as Undetectable = Untransmittable (U=U).

Question 7What if ART is not suppressing the virus?

A detectable or rising viral load does not automatically mean that no treatment options remain. The clinician will review missed doses, absorption, interactions with other medicines, the ART regimen and previous resistance results. Repeat viral-load testing and, when indicated, drug-resistance testing help guide the next regimen.

Repeatedly changing tablets without establishing the cause can limit future options. A structured, culture- and guideline-based review is especially important when HIV occurs together with tuberculosis or another opportunistic infection.

Question 8Who should manage advanced HIV?

Advanced HIV may involve several infections, complex drug interactions, organ dysfunction, IRIS and possible resistance at the same time. Care is best coordinated by a clinician experienced in HIV medicine, with other specialists involved when needed.

Dr Ankesh Gupta, DM Infectious Diseases from AIIMS New Delhi, provides confidential assessment and treatment for low CD4 counts, opportunistic infections, HIV with tuberculosis, treatment failure and suspected drug resistance at Choithram Hospital, Indore.

Medical note: This article provides general education and does not replace an individual clinical assessment. Treatment and test selection depend on symptoms, CD4 count, previous ART, pregnancy status, organ function and local protocols.